M&T Bank
CSTL icon

M&T Bank’s Castle Biosciences CSTL Stock Holding History

M&T Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,704
Closed -$436K – 1645
2022
Q1 		$436K Buy
+9,704
New +$401K ﹤0.01% 1051
2021
Q4 		– Sell
-3,186
Closed -$212K – 1593
2021
Q3 		$212K Hold
3,186
– – ﹤0.01% 1416
2021
Q2 		$234K Hold
3,186
– – ﹤0.01% 1385
2021
Q1 		$218K Hold
3,186
– – ﹤0.01% 1383
2020
Q4 		$214K Buy
+3,186
New +$173K ﹤0.01% 1489

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

M&T Bank's CSTL Position: Q2 2022 in Review

M&T Bank sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 9,704 shares — an estimated $436K sold.

M&T Bank first reported a position in CSTL in Q4 2020 and held it in 5 quarters. The position peaked at $436K in Q1 2022. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • M&T Bank reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • M&T Bank sold 9,704 Castle Biosciences shares in Q2 2022, an estimated $436K.
  • M&T Bank first reported a position in Castle Biosciences in Q4 2020 and held it in 5 quarters.
  • M&T Bank's Castle Biosciences position peaked at $436K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on M&T Bank's 13F filing for Q2 2022, filed 5 Aug 2022.